IQVIA™ Real-World Insights Bibliography

Healthcare costs of patients with Crohn's disease receiving certolizumab pagol with and without home health nurse assistance: results from a retrospective analysis of patient claims data
Author(s): Douglas C Wolf, Srihari Jaganathan, Chakkarin Burudpakdee, Arpamas Seetasith, Mohamed Yassine, Jay Gucky, Robert Low, David Schwartz
Affiliations(s): Atlanta Gastroenterology Associates; UCB Pharma; Medical and Scientific Services, Real-World Evidence Solutions, IQVIA
Publication(s):  Academy of Managed Care Pharmacy Managed Care & Specialty Pharmacy Annual Meeting
Document Type(s): Poster,
Countries: USA,
C:
Y:
Gastrointestinal disorders,
2017
  L:
A:
English
Population Based Study, Retrospective cohort analysis,
  Add to report
 
 
"Treating iron deficiency in patients with gastrointestinal disease: risk of re-attendance in secondary care "
Author(s): Tomkins, Susannah & Chapman, Callum & Myland, Melissa & Tham, Rachel & de Nobrega, Rachael & Jackson, Brinley & Keshav, Satish.
Affiliations(s): Lead author, Myland and Tham: IQVIA
Publication(s): 
Document Type(s): Article,
Countries: UK,
C:
Y:
Gastrointestinal disorders,
2017
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease
Author(s): Peyrin-Biroulet L1, Van Assche G2, Gómez-Ulloa D3, García-Álvarez L3, Lara N3, Black CM4, Kachroo S4.
Affiliations(s): 1Gastroenterology Department, Lorraine University, Vandoeuvre, France. 2Department of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. 3IMS Health, Real-World Evidence Solutions, Barcelona, Spain. 4Center for Observational and Real-World Evidence (CORE), Merck and Co, Inc, Kenilworth, New Jersey.
Publication(s):  : Clin Gastroenterol Hepatol. 2016 Jul 5. pii: S1542-3565(16)30372-X. doi: 10.1016/j.cgh.2016.06.025
Document Type(s): Abstract,
Countries: 
C:
Y:
Gastrointestinal disorders, Hematology,
2016
  L:
A:
English
Review,
  Add to report
 
 
Unspecified intestinal malabsorption associated with angiotensin receptor blocker therapy: results from a nationwide, population-based study in Italy and Germany.
Author(s): Ripellino C1, Cataldo N1, Scarpignato C.
Affiliations(s): 1 IMS Health Information Solutions Italy Srl, Milan, Italy.
Publication(s):  ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria.
Document Type(s): Poster,
Countries: Germany, Italy,
C:
Y:
Gastrointestinal disorders,
2016
  L:
A:
English
Clinical setting: Primary care, Database Study, Epidemiological study, Longitudinal study, Real World Data, Real World Evidence, Retrospective database analysis,
  Add to report
 
 
BIOLOGICS USE IN CROHN’S DISEASE IN France
Author(s): 1-Morand F, 2-Gaudry JL, 3-Willemin L, 4-Lee XY, 5-Lelli F
Affiliations(s): 1- IMS Health Paris France, 2- IMS Health Boulogne-Billancourt France, 3-Janssen-Cilag Issy-les-Moulineaux France, 4-Janssen-Cilag Birkerod Denmark, Janssen-Cilag Colgno Monzese Italy
Publication(s):  19th ISPOR Congress 2016
Document Type(s): Abstract, Poster,
Countries: France,
C:
Y:
Clinical practice, Gastrointestinal disorders,
2016
  L:
A:
English
Retrospective database analysis, Survey research,
  Add to report
 
 
Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study.
Author(s): Peyrin-Biroulet L1, Van Assche G2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11.
Affiliations(s): 1Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. Electronic address: peyrinbiroulet@gmail.com. 2Division of Gastroenterology, University Hospitals Leuven, Leuven Belgium. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom. 10IMS Health, Real World Evidence Solutions, Spain. 11Merck & Co., Inc., Kenilworth, NJ, United States
Publication(s):  Dig Liver Dis. 2016 Jun;48(6):601-7.
Document Type(s): Article,
Countries: Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK,
C:
Y:
Gastrointestinal disorders,
2016
  L:
A:
English
Burden of illness, Patient questionnaire, Survey research,
  Add to report
 
 
Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study
Author(s): Van Assche G1, Peyrin-Biroulet L2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11.
Affiliations(s): 1Division of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. Electronic address: gert.vanassche@uzleuven.be. 2Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica and Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, UK. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK. 10IMS Health, Real World Evidence Solutions, Barcelona, Spain. 11Merck & Co., Inc., Rahway, NJ, United States.
Publication(s):  Dig Liver Dis. 2016 Jun;48(6):592-600
Document Type(s): Article,
Countries: Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK,
C:
Y:
Gastrointestinal disorders,
2016
  L:
A:
English
Burden of illness, Patient questionnaire,
  Add to report
 
 
Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Results from the COMPANION Study
Author(s): Latour M1, Gerega S2, Millson B2, Bessette L3, Marshall JK4, Lebovic G5,6, Sung M2, Oraichi D2, Gaetano T1, Gazel S1, Laliberté MC1
Affiliations(s): 1 AbbVie Corporation, St. Laurent, Quebec, Canada 2 IMS Brogan, Kirkland, Quebec, Canada 3 Department of Medicine, Laval University, Quebec City, Quebec, Canada 4 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada 5 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 6 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
Publication(s):  American College of Gastroenterology 2016 Conference, October 14-19, Las Vegas, USA
Document Type(s): Poster,
Countries: Canada,
Click here for the abstract
C:
Y:
Gastrointestinal disorders, Medication compliance,
2016
  L:
A:
English
Database Study,
  Add to report
 
 
Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: a binational retrospective study
Author(s): Yaron Kinar, Nir Kalkstein, Pinchas Akiva, Bernard Levin, Elizabeth E Half, Inbal Goldshtein, Gabriel Chodick, Varda Shalev
Affiliations(s): Oxford Academic
Publication(s):  Journal of the American Medical Informatics Association
Document Type(s): Article,
Countries: UK,
C:
Y:
Gastrointestinal disorders,
2016
  L:
A:
English
  Add to report
 
 
Coste del síndrome del intestino irritable con predominio de estreñimiento en España
Author(s): Xavier Cortés1, Montse Roset2, Carmen Barrull2, Carolina Sais3, Anna Raya4
Affiliations(s):  1 Departamento Médico, Almirall S.A., Barcelona, España; 2 Health Economics & Outcomes Research, IMS Health, Barcelona, España; 3 IASIST, Barcelona, España; 4 Departamento de Marketing, Almirall S.A., Barcelona, España
Publication(s):  PharmacoEcon Span Res Artic (2016) 13(1):1-8.
Document Type(s): Article,
Countries: Spain,
Click here for the abstract
C:
Y:
Clinical practice, Gastrointestinal disorders, Health economics,
2016
  L:
A:
Spanish
Burden of illness, Clinical setting: Primary care, Cost analysis, Retrospective database analysis,
  Add to report
 
 
First Page Previous Page  2 of 11 Next Page Last Page